Cytokines in dementias

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Limited knowledge exists on the inflammatory components in Alzheimer's disease (AD) and vascular dementia (VAD).
• Recent findings indicate the presence of inflammatory cytokines in the cerebrospinal fluid (CSF) of patients with dementia.
• Distinct initial triggers in AD and VAD may converge on similar cytokine production pathways following neuronal injury.

Purpose of the Study:

• To review the role of pro-inflammatory and anti-inflammatory cytokines in dementia.
• To explore the impact of cytokines on glia cell activation, amyloidogenesis, vascular changes, white matter damage, and neurodegeneration.

Main Methods:

• Review of existing clinical studies and scientific literature.
• Analysis of the proposed mechanisms of cytokine involvement in dementia pathogenesis.
• Synthesis of evidence supporting shared inflammatory pathways in AD and VAD.

Main Results:

• Cytokines released in the central nervous system (CNS) may act similarly in AD and VAD.
• Cytokines can amplify pathological changes including amyloidogenesis, vascular amyloid accumulation, white matter lesions, and angiogenesis.
• Clinical studies show overlapping pathologies, such as white matter infarcts in AD and senile plaques in VAD.

Conclusions:

• Cytokine-mediated inflammation is a significant factor in the pathogenesis of both AD and VAD.
• Shared inflammatory cascades contribute to common neuropathological features observed in these dementia types.
• Understanding cytokine roles is crucial for developing targeted therapies for dementia.